Bleakley Financial Group LLC Buys 173 Shares of The Allstate Co. (NYSE:ALL)

Bleakley Financial Group LLC increased its stake in The Allstate Co. (NYSE:ALL) by 3.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,840 shares of the insurance provider’s stock after purchasing an additional 173 shares during the period. Bleakley Financial Group LLC’s holdings in Allstate were worth $1,108,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Northwest Investment Counselors LLC bought a new position in shares of Allstate in the first quarter worth $26,000. Versant Capital Management Inc boosted its stake in Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after buying an additional 78 shares in the last quarter. Family Firm Inc. acquired a new stake in shares of Allstate during the second quarter valued at about $38,000. MCF Advisors LLC boosted its stake in shares of Allstate by 33.9% during the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 84 shares in the last quarter. Finally, Sunbelt Securities Inc. boosted its stake in shares of Allstate by 38.5% during the first quarter. Sunbelt Securities Inc. now owns 363 shares of the insurance provider’s stock valued at $63,000 after purchasing an additional 101 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

Insider Buying and Selling

In other news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the sale, the chief executive officer now owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 192,530 shares of company stock worth $34,967,665. Corporate insiders own 1.80% of the company’s stock.

Allstate Stock Performance

Shares of ALL opened at $195.37 on Monday. The company has a market cap of $51.56 billion, a price-to-earnings ratio of 43.13, a P/E/G ratio of 1.74 and a beta of 0.48. The Allstate Co. has a 12 month low of $121.70 and a 12 month high of $198.79. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49. The business’s fifty day simple moving average is $186.66 and its two-hundred day simple moving average is $173.81.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $1.28. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The business had revenue of $15.71 billion during the quarter, compared to analyst estimates of $14.04 billion. During the same quarter in the previous year, the company posted ($4.42) earnings per share. Allstate’s revenue for the quarter was up 12.4% on a year-over-year basis. Research analysts anticipate that The Allstate Co. will post 15.19 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ALL has been the topic of a number of research analyst reports. Barclays assumed coverage on Allstate in a report on Wednesday, September 4th. They set an “underweight” rating and a $175.00 price target on the stock. Jefferies Financial Group lifted their target price on Allstate from $217.00 to $231.00 and gave the company a “buy” rating in a research report on Wednesday, October 9th. BMO Capital Markets boosted their price objective on Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research report on Friday. Raymond James boosted their target price on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. Finally, Bank of America boosted their price objective on Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research note on Friday. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $205.50.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.